There is a little bit there in the report but I pushed that he needs to produce this sometime in the future. I'm sure everybody (share holders, institutions, analysts) confidence would lift big time. I think if he has say 80, 100, 150M/yr revenue lock in for year after year then he should be able to give some guidelines on the other products.
Just a side issue - say in the pumps one drug may need 3 months to do a trial and another might need 12 mths. So he can't be too specific on things.
- Forums
- ASX - By Stock
- UNS
- factory visit - report
factory visit - report, page-5
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UNS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online